Conference & Meetings World Supplements Canada Supplement - Page 11

Halifax Ocean Nutrition Canada Limited (ONC), founded in 1997, is a global innovator and provider of quality marine-based natural health and nutrition products. ONC's primary product focus is MEG-3® brand Omega-3 EPA/DHA purified fish oil ingredients for the global dietary supplement and health food ingredient markets. The QEII Health Sciences Centre, meanwhile, is the largest adult academic health sciences centre in Atlantic Canada and has the highest number of certified clinical research coordinators among hospitals in North America. BIOTIC (BIOmedical Translational Imaging Centre) is a multi-site centre embedded in the two leading research and teaching hospitals in Nova Scotia. Its teams collaborate on commercial development projects with industry partners as well as R&D. Business costs in Halifax are competitive and there are many incentives to invest and relocate. Halifax is also competitive on labour costs and has the lowest average salary cost for each of the six key positions. Halifax has one of the highest attendance rates in Canada for meetings and conventions and three recent successful conferences at the end of 2018 included the International Conference on Residency Medicine for 700 delegates and the Canadian Society of Club Managers National Conference for 220 delegates, both in October, and the Royal LePage National Sales Conference, which drew 1,300 delegates in September. Above: Halifax has one of the highest attendance rates in Canada for meetings and conventions FAST FACTS: • Nova Scotia is known as a world leader in omega-3 fatty acid supplements. Nature’s Way Canada has the largest share of Canada’s omega-3 market and DSM Nutritional Products, located in Mulgrave, Nova Scotia, is the world's largest manufacturer of concentrated fish oil. • Acadian Seaplants is the world’s largest independent manufacturer of marine plant products and is exporting to 80 countries. • BioMedica Diagnostics is a leader in the province’s large medical technology area, impacting patients in 60 countries. • Immunovaccine Inc. is poised to revolutionise immunotherapy and has an estimated CAD$260m market cap. CONFERENCE & MEETINGS WORLD 11